The new omega-3 player is producing algae-based omega-3 eicosapentaenoic acid (EPA).
Aurora Algae Pty. Ltd. (West Perth, Western Australia) has announced several new milestones in its production of algae-based biomass.
On top of Aurora Algae opening a 20-acre demonstration facility in Karratha, Western Australia, the company has also secured an option agreement for more than 1500 acres of land near its demo facility to construct a full-scale commercial manufacturing facility.
Aurora Algae has also received $946,000 AUD in LEEDS grant funding and $750,000 AUD in R&D tax credits from the Australian government in addition to previous LEEDS funding.
These initiatives will enable the company to speed up commercialization of its algae biomass, intended for a variety of applications including vegetarian omega-3 eicosapentaenoic acid (EPA).
Aurora Algae produces algae-based biomass for the nutraceutical, pharmaceutical, aquaculture, and renewable energy markets. The company owns a U.S. processing center in Hayward, California while producing biomass in the “ideal environmental conditions” of Western Australia.